TRBN Insider Trading Activity and SEC Form 4 Filings
TRBN insider trading summary
No open-market insider purchases or sales of Trubion Pharmaceuticals, Inc (TRBN) have been reported on SEC Form 4 in the past 12 months.
Latest TRBN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2010 | Steven Lazarus | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Arch Venture Partners V LLC | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Arch Venture Fund V LP | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Healthcare Focus Fund LP | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Arch V Entrepreneurs Fund LP | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Robert Nelsen | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Arch Venture Fund V LP | 10% Owner | Sell | $0 (14,503 @ $0.00) |
| Oct 28, 2010 | Arch Venture Partners V LP | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
| Oct 28, 2010 | Arch V Entrepreneurs Fund LP | 10% Owner | Sell | $0 (14,503 @ $0.00) |
| Oct 28, 2010 | Clinton Bybee | 10% Owner | Sell | $0 (2,209,741 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.